{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:19:04Z","timestamp":1789147144312,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1208\/s12248-014-9605-8","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T13:16:02Z","timestamp":1398172562000},"page":"649-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Curcumin Inhibits the AKT\/NF-\u03baB Signaling via CpG Demethylation of the Promoter and Restoration of NEP in the N2a Cell Line"],"prefix":"10.1208","volume":"16","author":[{"given":"Yushuang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"9605_CR1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/475S2a","volume":"475","author":"A Abbott","year":"2011","unstructured":"Abbott A. Dementia: a problem for our age. Nature. 2011;475:S2\u20134. doi: 10.1038\/475S2a .","journal-title":"Nature"},{"key":"9605_CR2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nature01325","volume":"420","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature. 2002;420:879\u201384. doi: 10.1038\/nature01325 .","journal-title":"Nature"},{"key":"9605_CR3","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awt231","volume":"136","author":"T Revesz","year":"2013","unstructured":"Revesz T. Inflammation in Alzheimer\u2019s disease: insights from immunotherapy. Brain. 2013;136:2654\u20136. doi: 10.1093\/brain\/awt231 .","journal-title":"Brain"},{"key":"9605_CR4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD. AKT\/PKB signaling: navigating downstream. Cell. 2007;129:1261\u201374. doi: 10.1016\/j.cell.2007.06.009 .","journal-title":"Cell"},{"key":"9605_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/35019154","volume":"406","author":"M Delhase","year":"2000","unstructured":"Delhase M, Li N, Karin M. Kinase regulation in inflammatory response. Nature. 2000;406:367\u20138. doi: 10.1038\/35019154 .","journal-title":"Nature"},{"key":"9605_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/356103a0","volume":"356","author":"M Robertson","year":"1992","unstructured":"Robertson M. Alzheimer\u2019s disease and amyloid. Nature. 1992;356:103. doi: 10.1038\/356103a0 .","journal-title":"Nature"},{"key":"9605_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2990.1998.00116.x","volume":"24","author":"I Ferrer","year":"1998","unstructured":"Ferrer I, Mart\u00ed E, L\u00f3pez E, Tortosa A. NF-\u03baB immunoreactivity is observed in association with beta A4 diffuse plaques in patients with Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 1998;24:271\u20137. doi: 10.1046\/j.1365-2990.1998.00116.x .","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9605_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.expneurol.2012.05.004","volume":"236","author":"MR Gonzalo","year":"2012","unstructured":"Gonzalo MR, Martin B, Sanz-Anquela JM, Arevalo-Serrano J, Gonzalo-Ruiz A. Oligomers of beta-amyloid protein (Abeta1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brain. Exp Neurol. 2012;236:215\u201327. doi: 10.1016\/j.expneurol.2012.05.004 .","journal-title":"Exp Neurol"},{"key":"9605_CR9","doi-asserted-by":"crossref","first-page":"30259","DOI":"10.1074\/jbc.M401891200","volume":"279","author":"E Hama","year":"2004","unstructured":"Hama E, Shirotani K, Iwata N, Saido TC. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J Biol Chem. 2004;279:30259\u201364. doi: 10.1074\/jbc.M401891200 .","journal-title":"J Biol Chem"},{"key":"9605_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1385\/JMN:22:1-2:5","volume":"22","author":"RA Marr","year":"2004","unstructured":"Marr RA, Guan H, Rockenstein E, Kindy M, Gage FH, Verma I, et al. Neprilysin regulates amyloid beta peptide levels. J Mol Neurosci. 2004;22:5\u201311. doi: 10.1385\/JMN:22:1-2:5 .","journal-title":"J Mol Neurosci"},{"key":"9605_CR11","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1002\/cncr.22312","volume":"107","author":"J Dai","year":"2006","unstructured":"Dai J, Mikhail M, Navarro D, Taneja SS, Lee P, Christos P, et al. Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression. Cancer. 2006;107:2628\u201336. doi: 10.1002\/cncr.22312 .","journal-title":"Cancer"},{"key":"9605_CR12","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1210\/en.2006-0172","volume":"147","author":"H Ando","year":"2006","unstructured":"Ando H, Nagasaka T, Shibata D, Harata T, Shimomura Y, Goto M, et al. Neutral endopeptidase expressed by decidualized stromal cells suppresses akt phosphorylation and deoxyribonucleic acid synthesis induced by endothelin-1 in human endometrium. Endocrinology. 2006;147:5153\u20139. doi: 10.1210\/en.2006-0172 .","journal-title":"Endocrinology"},{"key":"9605_CR13","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.febslet.2005.09.054","volume":"579","author":"R Russo","year":"2005","unstructured":"Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A. Neprylisin decreases uniformly in Alzheimer\u2019s disease and in normal aging. FEBS Lett. 2005;579:6027\u201330. doi: 10.1016\/j.febslet.2005.09.054 .","journal-title":"FEBS Lett"},{"key":"9605_CR14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ceb.2007.04.002","volume":"19","author":"C Martin","year":"2007","unstructured":"Martin C, Zhang Y. Mechanisms of epigenetic inheritance. Curr Opin Cell Biol. 2007;19:266\u201372. doi: 10.1016\/j.ceb.2007.04.002 .","journal-title":"Curr Opin Cell Biol"},{"key":"9605_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2008.10.173","volume":"378","author":"KL Chen","year":"2009","unstructured":"Chen KL, Wang SS, Yang YY, Yuan RY, Chen RM, Hu CJ. The epigenetic effects of amyloid-beta (1\u201340) on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem Biophys Res Commun. 2009;378:57\u201361. doi: 10.1016\/j.bbrc.2008.10.173 .","journal-title":"Biochem Biophys Res Commun"},{"key":"9605_CR16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1349-7006.2006.00250.x","volume":"97","author":"M Takahashi","year":"2006","unstructured":"Takahashi M, Yoshida M, Igarashi M, Nakae D. Methylation of neutral endopeptidase 24.11 promoter in rat hepatocellular carcinoma. Cancer Sci. 2006;97:611\u20137.","journal-title":"Cancer Sci"},{"key":"9605_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","volume":"30","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009;30:85\u201394. doi: 10.1016\/j.tips.2008.11.002 .","journal-title":"Trends Pharmacol Sci"},{"key":"9605_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/biof.1066","volume":"39","author":"A Shehzad","year":"2013","unstructured":"Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors. 2013;39:69\u201377. doi: 10.1002\/biof.1066 .","journal-title":"Biofactors"},{"key":"9605_CR19","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1208\/aapsj080352","volume":"8","author":"RL Thangapazham","year":"2006","unstructured":"Thangapazham RL, Sharma A, Maheshwari RK. Multiplemolecular targets in cancer chemoprevention by curcumin. AAPS J. 2006;8:E443\u20139. doi: 10.1208\/aapsj080352 .","journal-title":"AAPS J"},{"key":"9605_CR20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1039\/c2ib20088k","volume":"4","author":"GP Nagaraju","year":"2012","unstructured":"Nagaraju GP, Aliya S, Zafar SF, Basha R, Diaz R, El-Rayes BF. The impact of curcumin on breast cancer. Integr Biol (Camb). 2012;4:996\u20131007. doi: 10.1039\/c2ib20088k .","journal-title":"Integr Biol (Camb)"},{"key":"9605_CR21","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","volume":"65","author":"H Hatcher","year":"2008","unstructured":"Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631\u201352. doi: 10.1007\/s00018-008-7452-4 .","journal-title":"Cell Mol Life Sci"},{"key":"9605_CR22","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","volume":"14","author":"N Dhillon","year":"2008","unstructured":"Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491\u20139. doi: 10.1158\/1078-0432 .","journal-title":"Clin Cancer Res"},{"key":"9605_CR23","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1002\/cncr.25414","volume":"116","author":"S Fu","year":"2010","unstructured":"Fu S, Kurzrock R. Development of curcumin as an epigenetic agent. Cancer. 2010;116:4670\u20136. doi: 10.1002\/cncr.25414 .","journal-title":"Cancer"},{"key":"9605_CR24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bmcl.2008.12.041","volume":"19","author":"Z Liu","year":"2009","unstructured":"Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, et al. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett. 2009;19:706\u20139. doi: 10.1016\/j.bmcl.2008.12.041 .","journal-title":"Bioorg Med Chem Lett"},{"key":"9605_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2013.08.002","volume":"341","author":"GP Nagaraju","year":"2013","unstructured":"Nagaraju GP, Zhu S, Wen J, Farris AB, Adsay VN, Diaz R, et al. Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer. Cancer Lett. 2013;341:195\u2013203. doi: 10.1016\/j.canlet.2013.08.002 .","journal-title":"Cancer Lett"},{"issue":"Meeting Abstrac","key":"9605_CR26","first-page":"lb574","volume":"27","author":"GP Nagaraju","year":"2013","unstructured":"Nagaraju GP, Zhu S, Ko JE, Shoji M, El-Rayes B. Anti-angiogenic effects of curcumin and its novel analogs EF-31 and UBS-109 in colorectal cancer. FASEB J. 2013;27(Meeting Abstract Supplement):lb574.","journal-title":"FASEB J"},{"key":"9605_CR27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375:754\u201360. doi: 10.1038\/375754a0 .","journal-title":"Nature"},{"key":"9605_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2009.09.007","volume":"622","author":"HS Kim","year":"2009","unstructured":"Kim HS, Lim JY, Sul D, Hwang BY, Won TJ, Hwang KW, et al. Neuroprotective effects of the new diterpene, CBNU06 against beta-amyloid-induced toxicity through the inhibition of NF-kappaB signaling pathway in PC12 cells. Eur J Pharmacol. 2009;622:25\u201331. doi: 10.1016\/j.ejphar.2009.09.007 .","journal-title":"Eur J Pharmacol"},{"key":"9605_CR29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/jnci\/dji311","volume":"97","author":"F Lyko","year":"2005","unstructured":"Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 2005;97:1498\u2013506. doi: 10.1093\/jnci\/dji311 .","journal-title":"J Natl Cancer Inst"},{"key":"9605_CR30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1471-4159.2006.03956.x","volume":"98","author":"ZF Wang","year":"2006","unstructured":"Wang ZF, Li HL, Li XC, Zhang Q, Tian Q, Wang Q, et al. Effects of endogenous \u03b2-amyloid overproduction on tau phosphorylation in cell culture. J Neurochem. 2006;98:1167\u201375. doi: 10.1111\/j.1471-4159.2006.03956.x .","journal-title":"J Neurochem"},{"key":"9605_CR31","doi-asserted-by":"crossref","first-page":"28897","DOI":"10.1074\/jbc.273.44.28897","volume":"273","author":"GJ Ding","year":"1998","unstructured":"Ding GJ, Fischer PA, Boltz RC, Schmidt JA, Colaianne JJ, Gough A, et al. Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem. 1998;273:28897\u2013905. doi: 10.1074\/jbc.273.44.28897 .","journal-title":"J Biol Chem"},{"key":"9605_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2013.03.010","volume":"139","author":"L Adwan","year":"2013","unstructured":"Adwan L, Zawia NH. Epigenetics: a novel therapeutic approach for the treatment of Alzheimer\u2019s disease. Pharmacol Ther. 2013;139:41\u201350. doi: 10.1016\/j.pharmthera.2013.03.010 .","journal-title":"Pharmacol Ther"},{"key":"9605_CR33","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","volume":"65","author":"JS Miners","year":"2006","unstructured":"Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2006;65:1012\u201321. doi: 10.1097\/01.jnen.0000240463.87886.9a .","journal-title":"J Neuropathol Exp Neurol"},{"key":"9605_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0024-3205(83)90455-1","volume":"33","author":"H Lentzen","year":"1983","unstructured":"Lentzen H, Monden I, Linke J, Palenker J. No evidence for enkephalinase A on neuronal cells. Life Sci. 1983;33:105\u20138. doi: 10.1016\/0024-3205(83)90455-1 .","journal-title":"Life Sci"},{"key":"9605_CR35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ijc.26028","volume":"130","author":"Y Hong","year":"2012","unstructured":"Hong Y, Beckett C, Belyaev ND, Turner AJ. The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int J Cancer. 2012;130:775\u201386. doi: 10.1002\/ijc.26028 .","journal-title":"Int J Cancer"},{"key":"9605_CR36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/embor.2008.222","volume":"10","author":"ND Belyaev","year":"2009","unstructured":"Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 2009;10:94\u2013100. doi: 10.1038\/embor.2008.222 .","journal-title":"EMBO Rep"},{"key":"9605_CR37","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/498S10a","volume":"498","author":"J Wright","year":"2013","unstructured":"Wright J. Epigenetics: reversible tags. Nature. 2013;498:S10\u20131. doi: 10.1038\/498S10a .","journal-title":"Nature"},{"key":"9605_CR38","doi-asserted-by":"crossref","first-page":"e57709","DOI":"10.1371\/journal.pone.0057709","volume":"8","author":"A Link","year":"2013","unstructured":"Link A, Balaguer F, Shen Y, Lozano JJ, Leung HC, Boland CR, et al. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS ONE. 2013;8:e57709. doi: 10.1371\/journal.pone.0057709 .","journal-title":"PLoS ONE"},{"key":"9605_CR39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bcp.2011.07.065","volume":"82","author":"TO Khor","year":"2011","unstructured":"Khor TO, Huang Y, Wu TY, Shu L, Lee J, Kong AN. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs emethylation. Biochem Pharmacol. 2011;82:1073\u20138. doi: 10.1016\/j.bcp.2011.07.065 .","journal-title":"Biochem Pharmacol"},{"key":"9605_CR40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1208\/s12248-011-9300-y","volume":"13","author":"L Shu","year":"2011","unstructured":"Shu L, Khor TO, Lee JH, Boyanapalli SS, Huang Y, Wu TY, et al. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J. 2011;13:606\u201314. doi: 10.1208\/s12248-011-9300-y .","journal-title":"AAPS J"},{"key":"9605_CR41","first-page":"675","volume":"4","author":"YL Liu","year":"2011","unstructured":"Liu YL, Yang HP, Gong L, Tang CL, Wang HJ. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines. Mol Med Rep. 2011;4:675\u20139. doi: 10.3892\/mmr.2011.473 .","journal-title":"Mol Med Rep"},{"key":"9605_CR42","doi-asserted-by":"crossref","first-page":"e55934","DOI":"10.1371\/journal.pone.0055934","volume":"8","author":"J Yu","year":"2013","unstructured":"Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, et al. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS ONE. 2013;8:e55934. doi: 10.1371\/journal.pone.0055934 .","journal-title":"PLoS ONE"},{"key":"9605_CR43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135. doi: 10.1126\/science.1566067 .","journal-title":"Science"},{"key":"9605_CR44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bcp.2007.01.005","volume":"73","author":"M Shakibaei","year":"2007","unstructured":"Shakibaei M, John T, Schulze TG, Lehmann I, Mobasheri A. Suppression of NF-\u03baB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007;73:1434\u201345. doi: 10.1016\/j.bcp.2007.01.005 .","journal-title":"Biochem Pharmacol"},{"key":"9605_CR45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1254\/jphs.10126SC","volume":"114","author":"K Moriyuki","year":"2010","unstructured":"Moriyuki K, Sekiguchi F, Matsubara K, Nishikawa H, Kawabata A. Curcumin inhibits the proteinase-activated receptor-2-triggered prostaglandin E2 production by suppressing cyclooxygenase-2 upregulation and Akt-dependent activation of nuclear factor-\u03ba B in human lung epithelial cells. J Pharmacol Sci. 2010;114:225\u20139. doi: 10.1254\/jphs.10126SC .","journal-title":"J Pharmacol Sci"},{"key":"9605_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.108.138719","volume":"327","author":"M Mosca","year":"2008","unstructured":"Mosca M, Lucciarini R, Perfumi MC, Santoni G. Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt\/survivin pathway and inhibition of caspase-3 activity. J Pharmacol Exp Ther. 2008;327:215\u201325. doi: 10.1124\/jpet.108.138719 .","journal-title":"J Pharmacol Exp Ther"},{"key":"9605_CR47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11011-010-9207-9","volume":"25","author":"W Li","year":"2010","unstructured":"Li W, Wu Y, Min F, Li Z, Huang J, Huang R. A nonhuman primate model of Alzheimer\u2019s disease generated by intracranial injection of amyloid-beta42 and thiorphan. Metab Brain Dis. 2010;25:277\u201384. doi: 10.1007\/s11011-010-9207-9 .","journal-title":"Metab Brain Dis"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-014-9605-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-014-9605-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-014-9605-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:47:59Z","timestamp":1559620079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-014-9605-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["9605"],"URL":"https:\/\/doi.org\/10.1208\/s12248-014-9605-8","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}